Axogen, Inc. — Director's Dealing 2014

Mar 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-03-13

Reporting Person: Zaderej Karen L. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-13	Common Stock	P	928	$3.50	Acquired	136302	Direct
2014-03-13	Common Stock	P	572	$3.47	Acquired	136874	Direct
2014-03-14	Common Stock	M	126	$0.27	Acquired	137000	Direct
2014-03-14	Common Stock	M	72222	$0.27	Acquired	209222	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-14	Stock Option (right to buy)	$0.27	M	126	Acquired	2018-11-18	Common Stock (126)	Direct
2014-03-14	Stock Option	$0.27	M	72222	Acquired	2020-06-09	Common Stock (72222)	Direct

Footnotes

F1: Shares purchased in open market transaction.